Allena Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced net loss was USD 13.972 million compared to USD 6.976 million a year ago. Basic loss per share from continuing operations was USD 0.24 compared to USD 0.26 a year ago. For the half year, net loss was USD 25.608 million compared to USD 14.561 million a year ago. Basic loss per share from continuing operations was USD 0.45 compared to USD 0.56 a year ago.